NASDAQ:TWST
Twist Bioscience Corp. Stock News
$42.37
-0.83 (-1.92%)
At Close: May 10, 2024
Twist Bioscience Corporation (TWST) CEO Emily Leproust on Q1 2021 Results - Earnings Call Transcript
05:56pm, Friday, 05'th Feb 2021
Twist Bioscience Corporation (TWST) CEO Emily Leproust on Q1 2021 Results - Earnings Call Transcript
Why Twist Bioscience Stock Is Tanking Today
11:33am, Friday, 05'th Feb 2021
An analyst downgraded the stock despite its better-than-expected quarterly results.
Recap: Twist Bioscience Q1 Earnings
05:06pm, Thursday, 04'th Feb 2021
Shares of Twist Bioscience (NASDAQ:TWST) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 28.00% over the past year to ($0.72), wh
Twist Bioscience (TWST) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
01:33pm, Thursday, 28'th Jan 2021
Twist Bioscience (TWST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF
08:21am, Wednesday, 27'th Jan 2021
One aspect of the ANEW ETF is focused on the bleeding edge of medical advances. Here's what you need to know if you're considering investing.
A Deep Dive into ARK ETFs
12:03pm, Wednesday, 20'th Jan 2021
We highlight the best performing ETFs managed by Cathie Wood
Twist Bioscience Supplies Centers for Disease Control and Prevention with Custom SARS-CoV-2 Synthetic RNA Controls
08:00am, Thursday, 07'th Jan 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #COVID19--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using i
Twist Bioscience to Offer Synthetic RNA Control for UK Variant Strain of SARS-CoV-2
08:00am, Wednesday, 23'rd Dec 2020
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #COVID19--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using i
The ENTR ETF: Once Incurable Afflictions Now Within Reach
12:12pm, Thursday, 17'th Dec 2020
The healthcare sector has been solid in 2020, but the truly impressive gains are coming by way of the companies disrupting the industry. Investors looking to access high-flying names such as CRISPR Th
The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF
03:13pm, Monday, 14'th Dec 2020
One aspect of the ANEW ETF is focused on the bleeding edge of medical advances. Here's what you need to know if you're considering investing.
These 5 Mid-Cap Healthcare Stocks Had the Best Gains in 2020
06:45am, Friday, 11'th Dec 2020
Investors favored coronavirus vaccine work, late-stage trial victories, and genetic sequencing.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its s
Twist Bioscience Announces Pricing of a $300 Million Upsized Public Offering of Common Stock
08:34pm, Wednesday, 02'nd Dec 2020
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its s
Twist Bioscience Announces Proposed Public Offering of Common Stock
04:01pm, Tuesday, 01'st Dec 2020
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its s
These Stocks Are Ready For Their 2021 Breakout (Video)
01:29pm, Monday, 30'th Nov 2020
These stocks look ripe for a 2021 breakout. Seeking Alpha Top Stocks makes it easy to find the strongest stocks in the market.